A single-administration therapeutic interfering particle reduces SARS-CoV-2 viral shedding and pathogenesis in hamsters
Preprint
Abstract
The high transmissibility of SARS-CoV-2 is a primary driver of the COVID-19 pandemic. While existing interventions prevent severe disease, they exhibit mixed efficacy in preventing transmission, presumably due to their limited antiviral effects in the respiratory mucosa, whereas interventions targeting the sites of viral replication might more effectively limit respiratory virus transmission. Recently, intranasally administered RNA-based therapeutic interfering particles (TIPs) were reported to suppress SARS-CoV-2 replication, exhibit a high barrier to resistance, and prevent serious disease in hamsters. Since TIPs intrinsically target the tissues with the highest viral replication burden (i.e., respiratory tissues for SARS-CoV-2), we tested the potential of TIP intervention to reduce SARS-CoV-2 shedding. Here, we report that a single, post-exposure TIP dose lowers SARS-CoV-2 nasal shedding and at 5 days post-infection infectious virus shed is below detection limits in 4 out of 5 infected animals. Furthermore, TIPs reduce shedding of Delta variant or WA-1 from infected to uninfected hamsters. Co-housed ‘contact’ animals exposed to infected, TIP-treated, animals exhibited significantly lower viral loads, reduced inflammatory cytokines, no severe lung pathology, and shortened shedding duration compared to animals co-housed with untreated infected animals. TIPs may represent an effective countermeasure to limit SARS-CoV-2 transmission. Significance COVID-19 vaccines are exceptionally effective in preventing severe disease and death, but they have mixed efficacy in preventing virus transmission, consistent with established literature that parenteral vaccines for other viruses fail to prevent mucosal virus shedding or transmission. Likewise, small-molecule antivirals, while effective in reducing viral-disease pathogenesis, also appear to have inconsistent efficacy in preventing respiratory virus transmission including for SARS-CoV-2. Recently, we reported the discovery of a single-administration antiviral Therapeutic Interfering Particle (TIP) against SARS-CoV-2 that prevents severe disease in hamsters and exhibits a high genetic barrier to the evolution of resistance. Here, we report that TIP intervention also reduces SARS-CoV-2 transmission between hamsters.Keywords
All Related Versions
This publication has 43 references indexed in Scilit:
- Multiparametric and semiquantitative scoring systems for the evaluation of mouse model histopathology - a systematic reviewBMC Veterinary Research, 2013
- Systematic Review of Mucosal Immunity Induced by Oral and Inactivated Poliovirus Vaccines against Virus Shedding following Oral Poliovirus ChallengePLOS Pathogens, 2012
- Autonomous Targeting of Infectious Superspreaders Using Engineered Transmissible TherapiesPLOS Computational Biology, 2011
- Blocking Interhost Transmission of Influenza Virus by Vaccination in the Guinea Pig ModelJournal of Virology, 2009
- Modelling viral and immune system dynamicsNature Reviews Immunology, 2002
- Using Monoclonal Antibodies to Prevent Mucosal Transmission of Epidemic Infectious DiseasesEmerging Infectious Diseases, 1999
- Clinical Pharmacokinetics of the Prodrug Oseltamivir and its Active Metabolite Ro 64-0802Clinical Pharmacokinetics, 1999
- Simple method of estimating severity of pulmonary fibrosis on a numerical scale.Journal of Clinical Pathology, 1988
- Defective Viral Particles and Viral Disease ProcessesNature, 1970
- EXPERIMENTAL TRANSMISSION OF INFLUENZA VIRUS INFECTION IN MICEJournal of Experimental Medicine, 1967